drugset / Trial / NCT03322293
Daylight Photodynamic Therapy for Actinic Keratosis
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized, single-blind controlled trial with parallel group design to determine whether daylight photodynamic therapy (PDT) affords a reduction in treatment symptoms of pain, burning, and pruritus as measured by 1) symptom level during the treatment period and 2) pain at the end of treatment exposure.
Timeline
- Start
- 2017-12-01
- Primary completion
- 2018-12-01
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aminolevulinic Acid | Diagnostic / imaging agent | 20 % | Topical |